Medullary carcinoma of breast with a novel germline mutation 1123T >G in exon 11 of BRCA1

Breast cancer, the most common malignancy in females, has an estimated 5-10% hereditary predisposition. BRCA1 is a tumor suppressor gene and is known to be responsible for breast cancer and breast-ovarian cancers running in families. In breast caner patients, several mutations in BRCA1 have been rep...

Full description

Saved in:
Bibliographic Details
Published inJournal of the College of Physicians and Surgeons--Pakistan Vol. 16; no. 9; pp. 606 - 607
Main Authors Moattar, Tariq, Kausar, Toheed, Aban, Muniba, Khan, Shaista, Pervez, Shahid
Format Journal Article
LanguageEnglish
Published Pakistan 01.09.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Breast cancer, the most common malignancy in females, has an estimated 5-10% hereditary predisposition. BRCA1 is a tumor suppressor gene and is known to be responsible for breast cancer and breast-ovarian cancers running in families. In breast caner patients, several mutations in BRCA1 have been reported throughout the gene. This report describes identification of a mutation in BRCA1 gene using protein truncation (PTT) assay in a patient with medullary carcinoma of breast who also had a family history of breast cancer. Following DNA sequencing, the mutation was confirmed as substitution of thymine at position 1123 with guanine of exon 11 (1123 T>G). This mutation can be added to the pool of known BRCA1 mutations in Pakistani population, which will help in developing a local screening panel of BRCA1 mutations.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1022-386X